Investigational Site Number 840013 — Wheaton, Maryland

Investigational Site Number 840013 is a clinical research site located in Wheaton, Maryland, United States 20902.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840013 has participated in 3 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wheaton

Browse all research sites in Maryland · View every site in Wheaton

• The Center for Rheumatology and Bone Research
• Research Site
• GSK Investigational Site
• Institute for Asthma and Allergy
• Pfizer Investigational Site
• Novartis Investigative Site
• Center for Rheumatology and Bone Research
• Institute for Asthma and Allergy PC
• Center For Rheumatology & Bone Research
• Maryland Oncology Hematology, P.A.
• ADARx Clinical Site

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840013?

Investigational Site Number 840013 has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840013 conducted?

Investigational Site Number 840013 has 3 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is Investigational Site Number 840013 accredited by Crixeo Clinical Trials?

Investigational Site Number 840013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.